BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004;4:1798-1804. [PMID: 15476479 DOI: 10.1111/j.1600-6143.2004.00550.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Said A, Lucey MR. Liver transplantation: an update. Curr Opin Gastroenterol. 2006;22:272-278. [PMID: 16550042 DOI: 10.1097/01.mog.0000218964.70935.3c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
2 Bie CQ, Yang DH, Tang SH, Huang W. The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res. 2009;39:779-785. [PMID: 19473429 DOI: 10.1111/j.1872-034x.2009.00514.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD. Survival benefit after liver transplantation: a single European center experience. Transplantation. 2009;88:826-834. [PMID: 19920783 DOI: 10.1097/tp.0b013e3181b26807] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Foxton MR, Kendrick S, Sizer E, Muiesan P, Rela M, Wendon J, Heaton ND, O'grady JG, Heneghan MA. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation. Transplant Int 2006;19:988-94. [DOI: 10.1111/j.1432-2277.2006.00377.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
5 Huang K, Hu JH, Wang HF, He WP, Chen J, Duan XZ, Zhang AM, Liu XY. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011; 17(29): 3448-3452 [PMID: 21876637 DOI: 10.3748/wjg.v17.i29.3448] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
6 Machicao VI. Model for End-Stage Liver Disease–Sodium Score. Clinics in Liver Disease 2017;21:275-87. [DOI: 10.1016/j.cld.2016.12.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Yang J, Yan B, Yang L, Li H, Fan Y, Zhu F, Zheng J, Ma X. Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study. BMC Gastroenterol 2018;18:161. [PMID: 30384828 DOI: 10.1186/s12876-018-0893-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Brock GN, Washburn K, Marvin MR. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing. PLoS One 2019;14:e0223053. [PMID: 31581270 DOI: 10.1371/journal.pone.0223053] [Reference Citation Analysis]
9 Mao W, Ye B, Lin S, Fu Y, Chen Y, Chen Y. Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment. ASAIO J. 2010;56:475-478. [PMID: 20613491 DOI: 10.1097/mat.0b013e3181e6bf13] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
10 Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-rockenschaub S, Soliman T, Wekerle T, Berlakovich GA, Steininger R, Muehlbacher F. Combination of Extended Donor Criteria and Changes in the Model for End-Stage Liver Disease Score Predict Patient Survival and Primary Dysfunction in Liver Transplantation: A Retrospective Analysis. Transplantation 2007;83:588-92. [DOI: 10.1097/01.tp.0000255319.07499.b7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
11 Herden U, Grabhorn E, Briem-richter A, Ganschow R, Nashan B, Fischer L. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant. Clin Transplant 2014;28:1061-8. [DOI: 10.1111/ctr.12420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
12 Massie AB, Luo X, Alejo JL, Poon AK, Cameron AM, Segev DL. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy. Liver Transpl. 2015;21:683-689. [PMID: 25762287 DOI: 10.1002/lt.24102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
13 Durand F, Belghiti J, Troisi R, Boillot O, Gadano A, Francoz C, de Hemptinne B, Mallet A, Valla D, Golmard JL. Living donor liver transplantation in high-risk vs. low-risk patients: Optimization using statistical models. Liver Transpl 2006;12:231-9. [DOI: 10.1002/lt.20700] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
14 Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation. 2011;92:469-476. [PMID: 21775931 DOI: 10.1097/tp.0b013e318225db4d] [Cited by in Crossref: 92] [Cited by in F6Publishing: 26] [Article Influence: 8.4] [Reference Citation Analysis]
15 Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Sci Rep 2019;9:8312. [PMID: 31165776 DOI: 10.1038/s41598-019-44814-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Campos-Varela I, Castells L. [Prognostic scores of cirrhosis]. Gastroenterol Hepatol 2008;31:439-46. [PMID: 18783690 DOI: 10.1157/13125591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Schiano T. MELD-good for many, not as good for others … at least for now. Hepatol Int 2013;7:306-8. [PMID: 26201766 DOI: 10.1007/s12072-012-9393-0] [Reference Citation Analysis]
18 Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl. 2012;18:434-443. [PMID: 22271656 DOI: 10.1002/lt.23394] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 10.7] [Reference Citation Analysis]
19 Wang LY, Fan YC, Zhao J, Gao S, Sun FK, Han J, Yang Y, Wang K. Elevated expression of tumour necrosis factor-α-induced protein 8 (TNFAIP8)-like 2 mRNA in peripheral blood mononuclear cells is associated with disease progression of acute-on-chronic hepatitis B liver failure. J Viral Hepat 2014;21:64-73. [PMID: 24329858 DOI: 10.1111/jvh.12116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
20 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wang Z, Yan L, Wang W, Xu M, Yang J. Impact of Pretransplant MELD Score on Posttransplant Outcome in Orthotopic Liver Transplantation for Patients with Acute-on-Chronic Hepatitis B Liver Failure. Transplantation Proceedings 2007;39:1501-4. [DOI: 10.1016/j.transproceed.2007.02.070] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
22 Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Scand J Gastroenterol 2009;44:346-57. [PMID: 18991165 DOI: 10.1080/00365520802530838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
23 Györi GP, Silberhumer GR, Rahmel A, de Vries E, Soliman T, Zehetmayer S, Rogiers X, Berlakovich GA; Eurotransplant. Impact of dynamic changes in MELD score on survival after liver transplantation - a Eurotransplant registry analysis. Liver Int 2016;36:1011-7. [DOI: 10.1111/liv.13075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011;15:685-698. [PMID: 22032523 DOI: 10.1016/j.cld.2011.08.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
25 Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, Boroń-Kaczmarska A. Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients. Clin Exp Hepatol 2018;4:240-6. [PMID: 30603671 DOI: 10.5114/ceh.2018.80125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Györi GP, Silberhumer GR, Zehetmayer S, Kern B, Hetz H, Soliman T, Steininger R, Mühlbacher F, Berlakovich GA. Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation: DeltaMELD predicts survival after liver transplantation. Transplant International 2012;25:935-40. [DOI: 10.1111/j.1432-2277.2012.01519.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zhao TY, Cong QW, Liu F, Yao LY, Zhu Y. Nonlinear Relationship Between Macrocytic Anemia and Decompensated Hepatitis B Virus Associated Cirrhosis: A Population-Based Cross-Sectional Study. Front Pharmacol 2021;12:755625. [PMID: 34616304 DOI: 10.3389/fphar.2021.755625] [Reference Citation Analysis]
28 Huo T, Wu J, Lee S. MELD in liver transplantation: the da Vinci code for the Holy Grail? Journal of Hepatology 2005;42:477-8. [DOI: 10.1016/j.jhep.2005.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
29 Barshes NR, Lee TC, Udell IW, O'mahoney CA, Karpen SJ, Carter BA, Goss JA. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl. 2006;12:475-480. [PMID: 16498644 DOI: 10.1002/lt.20703] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
30 Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009;9:72. [PMID: 19778459 DOI: 10.1186/1471-230X-9-72] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
31 Freeman RB. Reply. Journal of Hepatology 2005;42:478-9. [DOI: 10.1016/j.jhep.2005.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
32 Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, Ercolani G, Vivarelli M, Golfieri R, D'Errico Grigioni A, Panzini I, Morelli C, Bernardi M, Bolondi L, Pinna AD. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant. 2008;8:2547-2557. [PMID: 19032223 DOI: 10.1111/j.1600-6143.2008.02409.x] [Cited by in Crossref: 236] [Cited by in F6Publishing: 219] [Article Influence: 18.2] [Reference Citation Analysis]
33 Ripoll C, Lastra P, Rincón D, Catalina V, Bañares R. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis. Scand J Gastroenterol 2012;47:204-11. [PMID: 22242615 DOI: 10.3109/00365521.2011.645500] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
34 Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54:1297-1306. [PMID: 21145851 DOI: 10.1016/j.jhep.2010.11.008] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
35 Freeman RB Jr. The model for end-stage liver disease comes of age. Clin Liver Dis 2007;11:249-63. [PMID: 17606205 DOI: 10.1016/j.cld.2007.04.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
36 Cullaro G, Kim G, Pereira MR, Brown RS Jr, Verna EC. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis. Dig Dis Sci. 2017;62:3487-3494. [PMID: 29098551 DOI: 10.1007/s10620-017-4804-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
37 Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, Boroń-Kaczmarska A. Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis. Int J Environ Res Public Health 2020;17:E1727. [PMID: 32155772 DOI: 10.3390/ijerph17051727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
38 Zakareya T, Abbasy M, Abdel-razek W, Elsiesy H, Abal Khail F, Al Sebayel M, Waked I. Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality: . European Journal of Gastroenterology & Hepatology 2017;29:1424-7. [DOI: 10.1097/meg.0000000000000957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Gelu-Simeon M, Bayan T, Ostos M, Boufassa F, Teicher E, Steyaert JM, Bertucci I, Anty R, Pageaux GP, Meyer L, Duclos-Vallée JC; ANRS HC EP 25 PRETHEVIC study group. MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study). Medicine (Baltimore) 2015;94:e1239. [PMID: 26222860 DOI: 10.1097/MD.0000000000001239] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Wang LY, Meng QH, Zou ZQ, Fan YC, Han J, Qi ZX, Ge J, Xu AL, Wang SK, Wang K. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci. 2012;57:667-674. [PMID: 21984439 DOI: 10.1007/s10620-011-1930-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
41 Ravaioli M, Grazi GL, Ballardini G, Cavrini G, Ercolani G, Cescon M, Zanello M, Cucchetti A, Tuci F, Del Gaudio M. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant. 2006;6:1572-1577. [PMID: 16827857 DOI: 10.1111/j.1600-6143.2006.01354.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
42 Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl. 2007;13:1115-1124. [PMID: 17663412 DOI: 10.1002/lt.21154] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 5.7] [Reference Citation Analysis]
43 Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat. 2009;16:464-470. [PMID: 19413694 DOI: 10.1111/j.1365-2893.2008.01046.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
44 Huo TI, Lin HC, Wu JC, Hou MC, Lee FY, Lee PC, Chang FY, Lee SD. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant. 2006;20:188-194. [PMID: 16640525 DOI: 10.1111/j.1399-0012.2005.00463.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
45 Young AL, Rajagenashan R, Asthana S, Peters CJ, Toogood GJ, Davies MH, Lodge JPA, Pollard SG, Rajendra Prasad K. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom. Transplant Int 2007;20:331-7. [DOI: 10.1111/j.1432-2277.2006.00441.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
46 Spengler EK, Hunsicker LG, Zarei S, Zimmerman MB, Voigt MD. Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients. Hepatol Commun 2017;1:460-8. [PMID: 29404473 DOI: 10.1002/hep4.1053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805. [PMID: 17326206 DOI: 10.1002/hep.21563] [Cited by in Crossref: 1010] [Cited by in F6Publishing: 877] [Article Influence: 67.3] [Reference Citation Analysis]
48 Bennink RJ, Tulchinsky M, de Graaf W, Kadry Z, van Gulik TM. Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med 2012;42:124-37. [PMID: 22293167 DOI: 10.1053/j.semnuclmed.2011.10.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
49 Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X, Li M, Ma L. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis. 2012;31:2673-2678. [PMID: 22569645 DOI: 10.1007/s10096-012-1613-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
50 Firozvi AA, Lee CH, Hayashi PH. Greater travel time to a liver transplant center does not adversely affect clinical outcomes. Liver Transpl 2008;14:18-24. [DOI: 10.1002/lt.21279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
51 Ravaioli M, Masetti M, Ridolfi L, Capelli M, Grazi GL, Venturoli N, Di Benedetto F, Bianchi FB, Cavrini G, Faenza S, Begliomini B, Pinna AD, Gerunda GE, Ballardini G. Laboratory Test Variability and Model for End-Stage Liver Disease Score Calculation: Effect on Liver Allocation and Proposal for Adjustment. Transplantation 2007;83:919-24. [DOI: 10.1097/01.tp.0000259251.92398.2a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
52 Brown R, Emond JC. Managing Access to Liver Transplantation: Implications for Gastroenterology Practice. Gastroenterology 2007;132:1152-63. [DOI: 10.1053/j.gastro.2007.01.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Garonzik-wang JM, James NT, Arendonk KJV, Gupta N, Orandi BJ, Hall EC, Massie AB, Montgomery RA, Dagher NN, Singer AL, Cameron AM, Segev DL. The Aggressive Phenotype Revisited: Utilization of Higher-Risk Liver Allografts: Liver Aggressive-Center Phenotype. American Journal of Transplantation 2013;13:936-42. [DOI: 10.1111/ajt.12151] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
54 Gitto S, Lorenzini S, Biselli M, Conti F, Andreone P, Bernardi M. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Dig Liver Dis 2009;41:700-6. [PMID: 19502118 DOI: 10.1016/j.dld.2009.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
55 Cheng XP, Zhao J, Chen Y, Meng FK, Xu B, Yu HW, Meng QH, Liu YM, Zhang SB, Meng S, Zhang JY, Zhang JY, Duan ZP, Zheng SJ. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:444-448. [PMID: 26649802 DOI: 10.1097/meg.0000000000000538] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
56 Ravaioli M, Masetti M, Dazzi A, Romano A, Spaggiari M, Grazi GL, Ercolani G, Cescon M, Di Gioia P, De Ruvo N, Montalti R, Ballarin R, Di Benedetto F, Ridolfi L, Alvaro N, Ramacciato G, Morelli C, Gerunda E, Pinna AD. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers. Transplant Proc 2008;40:1814-5. [PMID: 18675057 DOI: 10.1016/j.transproceed.2008.05.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
57 Jacob M, Lewsey JD, Sharpin C, Gimson A, Rela M, van der Meulen JHP. Systematic review and validation of prognostic models in liver transplantation. Liver Transpl 2005;11:814-25. [PMID: 15973726 DOI: 10.1002/lt.20456] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
58 Goudsmit BFJ, Braat AE, Tushuizen ME, Coenraad MJ, Vogelaar S, Alwayn IPJ, van Hoek B, Putter H. Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure. JHEP Rep 2021;3:100369. [PMID: 34765960 DOI: 10.1016/j.jhepr.2021.100369] [Reference Citation Analysis]
59 Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049-1061. [PMID: 16799946 DOI: 10.1002/lt.20824] [Cited by in Crossref: 204] [Cited by in F6Publishing: 182] [Article Influence: 12.8] [Reference Citation Analysis]
60 Pannu AK, Bhalla A, Rao C, Singh C. Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure. Int J Crit Illn Inj Sci 2017;7:252-5. [PMID: 29291180 DOI: 10.4103/IJCIIS.IJCIIS_122_16] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Basto ST, Villela-nogueira CA, Tura BR, Coelho HSM, Ribeiro J, Fernandes ESM, Schmal AF, Victor L, Luiz RR, Perez RM. Risk factors for long-term mortality in a large cohort of patients wait-listed for liver transplantation in Brazil: Risk Factors for Long-Term Mortality. Liver Transpl 2011;17:1013-20. [DOI: 10.1002/lt.22344] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
62 Freeman RB, Harper A, Edwards EB. Liver transplantation outcomes under the model for end-stage liver disease and pediatric end-stage liver disease: . Current Opinion in Organ Transplantation 2005;10:90-4. [DOI: 10.1097/01.mot.0000161760.02748.ce] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Siparsky N, Axelrod D, Freeman RB. Organ Allocation in Liver Transplantation: Ethics, Organ Supply, and Evidencebased Practice. In: Clavien P, Trotter JF, editors. Medical Care of the Liver Transplant Patient. Oxford: Wiley-Blackwell; 2012. pp. 75-87. [DOI: 10.1002/9781444398441.ch7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19:105-115. [PMID: 23837134 DOI: 10.3350/cmh.2013.19.2.105] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
65 Potluri VS, Sokolich J, Buggs J, Mcclellan W, Rogers E, Barber K, Cocuy K, Kumar A, Bowers V. Outcomes in Hepatocellular Carcinoma Liver Transplantation before and after the Mandated Six-Month Wait Time. The American Surgeon 2019;85:900-3. [DOI: 10.1177/000313481908500845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Acar Ş, Akyıldız M, Gürakar A, Tokat Y, Dayangaç M. Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation. Turk J Gastroenterol 2020;31:782-9. [PMID: 33361041 DOI: 10.5152/tjg.2020.18761] [Reference Citation Analysis]
67 Huo TI, Lin HC, Lee SD. Model for end-stage liver disease and organ allocation in liver transplantation: where are we and where should we go? J Chin Med Assoc. 2006;69:193-198. [PMID: 16835979 DOI: 10.1016/S1726-4901(09)70217-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
68 Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652-1660. [PMID: 16697729 DOI: 10.1053/j.gastro.2006.02.010] [Cited by in Crossref: 424] [Cited by in F6Publishing: 377] [Article Influence: 26.5] [Reference Citation Analysis]
69 Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol. 2010;7:659-668. [PMID: 21045793 DOI: 10.1038/nrgastro.2010.169] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
70 Freeman RB. Mathematical models and behavior: assessing delta MELD for liver allocation. Am J Transplant 2004;4:1735-6. [PMID: 15476468 DOI: 10.1111/j.1600-6143.2004.00644.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
71 King A, Barton D, Beard HA, Than N, Moore J, Corbett C, Thomas J, Guo K, Guha I, Hollyman D, Stocken D, Yap C, Fox R, Forbes SJ, Newsome PN. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open 2015;5:e007700. [PMID: 25795699 DOI: 10.1136/bmjopen-2015-007700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
72 Tsuang WM, Vock DM, Copeland CAF, Lederer DJ, Palmer SM. An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med 2013;158:650-7. [PMID: 23648947 DOI: 10.7326/0003-4819-158-9-201305070-00004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
73 D'Amico G. Developing concepts on MELD: delta and cutoffs. J Hepatol 2005;42:790-2. [PMID: 15885348 DOI: 10.1016/j.jhep.2005.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
74 Novelli G, Rossi M, Ferretti G, Pugliese F, Travaglia D, Guidi S, Novelli S, Lai Q, Morabito V, Berloco PB. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Transplant Proc 2010;42:1182-7. [PMID: 20534256 DOI: 10.1016/j.transproceed.2010.03.095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
75 Singal AK, Kamath PS. Model for End-stage Liver Disease. J Clin Exp Hepatol. 2013;3:50-60. [PMID: 25755471 DOI: 10.1016/j.jceh.2012.11.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
76 Schilsky ML, Moini M. Advances in liver transplantation allocation systems. World J Gastroenterol 2016; 22(10): 2922-2930 [PMID: 26973389 DOI: 10.3748/wjg.v22.i10.2922] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
77 Yang YW, Wu CH, Hu RH, Ho MC, Tsai MK, Wu YM, Lee PH. Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center. Hepatol Int. 2010;4:507-510. [PMID: 20827408 DOI: 10.1007/s12072-010-9180-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
78 Ruf AE, Dirchwolf M, Biggins SW, Villamil FG. Revising metrics for aggressiveness assessment in liver transplantation centers. J Hepatol 2016;65:1066-7. [PMID: 27476766 DOI: 10.1016/j.jhep.2016.06.033] [Reference Citation Analysis]
79 Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI, Lee PC, Lee JY, Lee SD. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. Dig Liver Dis. 2010;42:137-142. [PMID: 19595648 DOI: 10.1016/j.dld.2009.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]